Background: Hilar cholangiocarcinoma (HC) represents an aggressive tumor embedded in an anatomically sensitive area. Surgeons must balance the goal of obtaining negative margins with the need to preserve critical vascular structures as well as enough proximal tissue to permit a feasible bilioenteric reconstruction. This study aims to revisit the importance of obtaining an R0 resection when excising HC in the era of modern adjuvant therapy. Methods: A retrospective review of a prospectively maintained database was employed to compile a list of patients with HC who were taken to the operating room with curative intent at our institution from 2008 to 2016. Those cases that resulted in resection were subjected to further analysis, with a focus on oncologic outcomes. Patients with both R0 and R1 margins underwent adjuvant chemoradiation. Results: 101 patients were included in the study. 71 resections were aborted after diagnostic laparoscopy and liver/portal ultrasonography, either because of peritoneal metastasis, or local disease extending beyond what was seen on preoperative imaging (Bismuth-Corlette T4/MSK T3). 30 patients underwent resection. Details of their cases and outcomes are included in Fig. 1. There were no cases of R2 resection. 2 year overall and progression free survival were similar between R0 and R1 resection groups (p = 0.86). Nodal status, grade, and lymphovascular invasion were also similar between the two groups. Conclusion: As with the resection of any malignancy, principles of oncologic resection should be adhered to when resecting cholangiocarcinoma. Striving for microscopically negative margins is one of those principles; however, given the technical difficulty of obtaining a proximal margin, it should be considered that R1 resection does not preclude a comparable oncologic outcome, provided patients are treated with adjuvant chemoradiation.Table 1Demographics, perioperative data, and complication data for HC resectionCharacteristicQuantityDemographic and procedural data Patients taken to the OR with curative intent101 Procedures where resection was actually performed30Male, No. (%)21 (70%)Female, No. (%)9 (30%)Age in years, median (range)63.5 (39–79)Major hepatectomy performed, No. (%)25 (83.3%)Bile duct resection alone, No. (%)5 (16.7%)Oncologic details AJCC T stage No. (%)T12 (6.7%)T216(53.3%)T312 (40%) Histologic Grade, No. (%)Well differentiated (G1)4(13.3%)Well-moderately differentiated (G1-2)4 (13.3%)Moderately differentiated (G2)12 (40%)Moderate-poorly differentiated (G2-3)7 (23%)Poorly differentiated (G3)3 (10%) Tumor size in mm, median (range)29 (8–70) R0 resection17 (57.7%) R1 resection13 (43.3%) Cases with lymphovascular invasion, No. (%)7 (23.3%) Cases with positive lymph nodes, No. (%)9 (30%) Cases with perineural invasion, No. (%)25 (83%)Outcomes data 30 day mortality, No. (%)2 (6.7%) 90 day mortality, No. (%)3 (10%) Median follow up, months30.5 2 year overall survival (%)90% 2 year progression free survival (%)63.3%2 year PFS with R0 resection64.7%2 year PFS with R1 resection62.0% Time to recurrence in months, median (range)21.3 (3.8–52.1)Abbreviations: HC, hilar Cholangiocarcinoma: AJCC, American Joint Committee on Cancer; PFS, progression free survival Open table in a new tab Abbreviations: HC, hilar Cholangiocarcinoma: AJCC, American Joint Committee on Cancer; PFS, progression free survival